Tus kws kho mob
QP38-18 Learning Environment for Risk Adjustment and Value Based Topics
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2441 - 2450 ntawm 4269
Tus kws kho mob
QP16-18 Pharmacy Benefit Update - Endari Exclusion
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 08, 2018
Tus kws kho mob
QP23-17 New Pre-Authorization Form for Reduction Mammoplasty
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 30, 2017
Tus kws kho mob
QP42-17 Professional Providers FAQ for Restricted Recipient Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 04, 2017
Tus kws kho mob
QP26-17 Reporting Healthcare Common Procedure Coding System (HCPCS) on Hospital Outpatient Claims
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 10, 2017
Tus kws kho mob
QP19-17 Durable Medical Equipment Cures Act
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2017
Tus kws kho mob
QP25-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Samsca (tolvaptan)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 19, 2018
Tus kws kho mob
QP28-18 Vision Benefit Available on Availity
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 25, 2018
Tus kws kho mob
QP87-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Lucemyra
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP47-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Opioids Extended Release
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 11, 2018